Håkan Mellstedt
Founder at KANCERA AB
Network origin in Håkan Mellstedt first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Karolinska Institutet
116
| College/University | Other Consumer Services | 116 |
19
| Public Company | Pharmaceuticals: Major | 19 |
Karolinska University Hospital
 Karolinska University Hospital Hospital/Nursing ManagementHealth Services Karolinska University Hospital is a premier health facility and one of Europe's largest teaching hospitals located in Stockholm, Sweden. The Swedish company provides healthcare services for a wide range of disorders, from major public health diseases to rare medical conditions. As a designated provider of highly specialized medical services, they have a primary responsibility for the clinical components of research and education. Together with the world-respected Karolinska Institutet, they lead in medical breakthroughs. The company educates and train tomorrow's medical specialists and healthcare professionals as a major teaching hospital.
3
| Non-Profit Organization | Hospital/Nursing Management | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Håkan Mellstedt via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ASTRAZENECA PLC | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Cellectricon AB
 Cellectricon AB Miscellaneous Commercial ServicesCommercial Services Cellectricon AB provides cell-based screening services to accelerate drug discovery. The firm develops and validates exciting central nervous system and peripheral pain assays using primary cells, accelerating the path from assay validation to compound screening. Its system is equipped with an imaging-based microplate reader to simultaneously record transient fluorescence and luminescence signals, providing real-time monitoring and readouts of cell culture response. The company was founded by Jan Owe Owesson Orwar, Daniel T. Chiu and Stig Anders Jakob Lindberg in 1999 and is headquartered in Molndal, Sweden. | Miscellaneous Commercial Services | Founder Director/Board Member | |
Athera Biotechnologies AB
 Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Athera Biotechnologies AB operates as a biopharmaceutical company which focuses on developing targeted anti-inflammatory biological candidate drugs and companion diagnostics. It has a proprietary program the fully human antibody PC-mAb. The frim develops a biomarker and companion diagnostic CVDefine® kit. Its PC-mAb is a fully human monoclonal antibody which neutralizes a key driver of vascular inflammation, phosphorylcholine, which targets market of reducing secondary cardiovascular events, focusing on high-risk patients with low anti-PC levels. The company was founded by Johan Frostegard in 2002 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member Founder Director/Board Member | |
| MEDIVIR AB | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member | |
Royal Swedish Academy of Sciences
 Royal Swedish Academy of Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Sciences provides research and development services on sciences. The non-profit company is based in Stockholm, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
The General Hospital Corp.
 The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| OREXO AB | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| University of Uppsala | College/University | Doctorate Degree Graduate Degree Masters Business Admin Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Undergraduate Degree Graduate Degree | |
Biolipox AB
 Biolipox AB Pharmaceuticals: MajorHealth Technology Biolipox AB develops and manufactures pharmaceuticals products. The company engages in the research and development of pharmaceuticals for the treatment of respiratory and other inflammatory diseases such as asthma, chronic obstructive pulmonary disease, rhinitis, pain, and arthritis. It was founded in June 2000 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
Newron Sweden AB
 Newron Sweden AB Pharmaceuticals: MajorHealth Technology Newron Sweden AB is a biopharmaceutical company engaged in the development of novel therapies for the treatment of disorders of the central nervous systems. The company was founded by Jonas Cristopher Frisen and Ann Marie Janson in 1998 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Founder Chief Tech/Sci/R&D Officer | |
| University of Stockholm | College/University | Doctorate Degree Undergraduate Degree Director/Board Member Graduate Degree Doctorate Degree | |
| ONCOPEPTIDES AB | Pharmaceuticals: Major | Founder Corporate Officer/Principal | |
| Royal Institute of Technology | College/University | Corporate Officer/Principal Graduate Degree Doctorate Degree | |
| University of Lund | College/University | Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
| Nanyang Technological University | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Royal Swedish Academy of Engineering Sciences
 Royal Swedish Academy of Engineering Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Engineering Sciences (IVA) is an organization that brings together around 1,300 academy members and 250 companies to bridge the gap between academia, business, and politics. The non-profit company is based in Stockholm, Sweden. The Swedish company's aim is to work towards people's ability to contribute positively to society. The organization runs an internship program called Tekniksprånget, which gives young people in Sweden the opportunity to test the engineering profession through a four-month paid internship. The program has been running since 2012 and aims to inspire more people to choose a higher technical education. The CEO of the company is Björn O. Nilsson. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| University of Gothenburg | College/University | Doctorate Degree Corporate Officer/Principal | |
AnaMar AB
 AnaMar AB Pharmaceuticals: MajorHealth Technology AnaMar AB develops drugs and provides research services for chronic joint diseases. It focuses on the discovery, development and commercialization of novel therapeutic strategies to treat debilitating inflammation and pain. The company was founded in 1998 and is headquartered in Lund, Sweden. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member Chief Tech/Sci/R&D Officer | |
| Astra Arcus AB | Corporate Officer/Principal Corporate Officer/Principal | ||
Rhenman & Partners Asset Management AB
 Rhenman & Partners Asset Management AB Investment ManagersFinance Rhenman & Partners Asset Management AB (Rhenman & Partners) is an independent Swedish alternative investment management firm which was founded in 2008 by a group of senior asset management industry executives including Henrik Rhenman and Göran Nordström. Headquartered in Stockholm, the firm is exclusively focused on the healthcare sector and manages the Rhenman Healthcare Equity L/S Fund, supported by a Scientific Advisory Board with a network of scientists and experts at renowned scientific institutions, including the Karolinska Institute and the University of Uppsala. | Investment Managers | Chairman Analyst-Equity | |
| BIOARCTIC AB | Pharmaceuticals: Major | Founder Director/Board Member | |
Karolinska Institutet Innovations AB
 Karolinska Institutet Innovations AB Financial ConglomeratesFinance Karolinska Institutet Innovations AB enables education, professional networking, funding, expertise in entrepreneurship and business development, and incubation opportunities for life science projects and companies. The company was founded in 1996 and is headquartered in Solna, Sweden. | Financial Conglomerates | Chairman Director/Board Member Director/Board Member Director/Board Member | |
iNovacia AB
 iNovacia AB Miscellaneous Commercial ServicesCommercial Services Part of Kancera AB, iNovacia AB is a Swedish company that provides pre-clinical research services. The company is based in Stockholm, Sweden. The company was founded by Martin Norin, Carl Johan Kördel, Philippe Verwaerde. Thomas Olin has been the CEO of the company since 2006. iNovacia was acquired by Kancera AB on February 17, 2011 for $0.05 million. | Miscellaneous Commercial Services | Chief Executive Officer Founder | |
| Center for Molecular Medicine (Sweden) | Director/Board Member Corporate Officer/Principal | ||
| NEOS AB | Medical Specialties | Director/Board Member Founder Founder | |
| INTERVACC AB | Biotechnology | Chief Executive Officer Director/Board Member | |
| KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Director/Board Member Chairman Director/Board Member Director/Board Member Director/Board Member Chief Operating Officer Director/Board Member | |
Palette Life Sciences AB
 Palette Life Sciences AB Medical SpecialtiesHealth Technology Palette Life Sciences AB operates as a pharmaceutical company. It specializes in developing products for local pain relief in obstetrics and gynecology. The company was founded by Berith Karlsson Tingåker, Gunvor Ekman-Ordeberg, Arne Folke Brodin and Lars Irestedt in 2009 and is headquartered in Solna, Sweden. | Medical Specialties | Director/Board Member Director/Board Member Founder | |
| INHALATION SCIENCES SWEDEN AB | Medical Specialties | Director/Board Member Founder | |
| DIAMYD MEDICAL AB | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| MENDUS AB | Biotechnology | Director/Board Member Director/Board Member | |
| Blasieholmen Investment Group AB | Director/Board Member Director/Board Member | ||
| PEPTONIC MEDICAL AB | Pharmaceuticals: Major | Director/Board Member Founder | |
| SALTX TECHNOLOGY HOLDING AB | Electronic Production Equipment | Chairman Chief Executive Officer | |
| NICOCCINO HOLDING AB | Tobacco | Director/Board Member Director of Finance/CFO | |
| KARESSA PHARMA HOLDING AB (PUBL) | Pharmaceuticals: Major | Chairman Director of Finance/CFO Director/Board Member Director/Board Member | |
| KLARIA PHARMA HOLDING AB | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Director/Board Member Chief Executive Officer | |
Klaria AB
 Klaria AB Pharmaceuticals: MajorHealth Technology Part of Klaria Pharma Holding AB, Klaria AB develops pharmaceuticals. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| INITIATOR PHARMA A/S | Pharmaceuticals: Major | Chairman Director/Board Member | |
| IRLAB THERAPEUTICS AB | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer | |
| Stockholm Brain Institute | Director/Board Member Director/Board Member | ||
| ISR IMMUNE SYSTEM REGULATION HOLDING AB (PUBL) | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Gesynta Pharma AB
 Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Founder Chief Tech/Sci/R&D Officer Founder Director/Board Member | |
Allarity Therapeutics A/S
 Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| APREA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Founder | |
| BACTIGUARD HOLDING AB | Medical Specialties | Director/Board Member Director/Board Member |
Statistics
International
| Sweden | 44 |
| United States | 3 |
| Denmark | 3 |
| United Kingdom | 2 |
| Austria | 2 |
Sectoral
| Health Technology | 29 |
| Consumer Services | 7 |
| Commercial Services | 6 |
| Finance | 5 |
| Health Services | 2 |
Operational
| Director/Board Member | 423 |
| Corporate Officer/Principal | 222 |
| Chairman | 104 |
| Independent Dir/Board Member | 76 |
| Founder | 68 |
Most connected contacts
- Stock Market
- Insiders
- Håkan Mellstedt
- Company connections
